Stock Analysis
iRhythm Technologies, Inc. (IRTC) Stock Analysis
iRhythm Technologies, Inc. (IRTC) stock analysis covering valuation, fundamentals, technical indicators, risk, AIQ Momentum, analyst catalysts, dividends, and the current AIQ Score.
iRhythm Technologies, Inc. (IRTC) currently has an AIQ Score of 44/100, indicating a bearish setup. Quality is the strongest factor at 58/100. Momentum is the weakest current factor at 34/100. Technical, fundamental, catalyst, dividend, and risk evidence should be read together at the latest market-close snapshot.
IRTC at a Glance
Crawlable current metrics from the latest market-close stock snapshot.
| Metric | Current |
|---|---|
| Price | $94.87 |
| AIQ Score | 44/100 |
| Overall View | Bearish |
| Technical Analysis Consensus | Strong Sell |
| Market Cap | $3.04B |
| P/E Ratio (TTM) | -76.64 |
| Forward P/E | — |
| EPS (Q3 FY2026) | -$0.90 |
| Revenue (Q3 FY2026) | $221.59M |
| Dividend Yield (TTM) | 0.00% |
| Beta | 0.5 |
| Volume | 1.2M |
| 52-week range | $82.85-$192.47 |
| RSI 14 | 35.33 |
| 50-Day SMA | $111.76 |
| 200-Day SMA | $119.60 |
| Analyst Price Target | $177.00 |
| Next Earnings | Feb 18, 2027 |
IRTCiRhythm Technologies, Inc.
Healthcare / Medical - Devices
Low Priority
Relative Laggard
Latest quote
- Momentum34
- Value43
- Quality58
- Risk resilience44
- Sentiment—
IRTC Stock Analysis Summary
iRhythm Technologies, Inc. (IRTC) currently has an AIQ Score of 44/100, indicating a bearish setup. Quality is the strongest factor at 58/100. Momentum is the weakest current factor at 34/100. Technical, fundamental, catalyst, dividend, and risk evidence should be read together at the latest market-close snapshot.
In a bearish regime, IRTC has AIQ Score of 44/100 with Quality base of 58/100 and fading Momentum at 34/100. Wait for component alignment before adding exposure.
Quality (58/100) leads while Momentum (34/100) lags. This cross-factor spread creates entry timing uncertainty.
Healthcare · 5.80% stock move · IRTC classified in Medical - Devices.
Current Evidence
AlgovestIQ Evidence Summary
Current consensus, supporting evidence, recent changes, and what would strengthen or weaken the view.
Is IRTC Bullish or Bearish Right Now?
IRTC currently has a bearish overall setup. Quality is the strongest factor at 58/100, while Momentum is weakest at 34/100. The current evidence suggests a bearish setup.
- - Analyst target implies +86.57% upside from the latest quote.
- - Value is the current constraint at 43/100.
- - Momentum is weak at 34/100.
- - Risk Resilience is weak at 44/100.
- - Price is -23.15% below its 200-day SMA.
- - Technical consensus has more sell votes than buy votes (36 vs 7).
Current Consensus
IRTC's Technical Analysis Consensus is currently Strong Sell, with 7 buy, 3 neutral, and 36 sell votes. IRTC's 14-day RSI is 35.33, which places the stock in a weaker momentum range. IRTC's beta is 0.5, indicating lower market sensitivity than the broad market.
What Changed in IRTC?
The largest recent change in IRTC is Momentum moving down by 23.0 points over the available 7-day comparison window. Quality remains the strongest visible factor.
What Would Change the IRTC Outlook?
The current bearish outlook could improve if AIQ reaches 65 (Bullish), momentum recovers, earnings revisions strengthen, and price confirms a stronger trend above the 50-day and 200-day moving averages. It would weaken if AIQ falls below 50 (Bearish), price loses long-term moving-average support, analyst expectations deteriorate, or risk evidence worsens.
AIQ 65+ (Bullish), RSI above 55, price above SMA-50/SMA-200, and positive catalyst or estimate-revision evidence.
AIQ below 50 (Bearish), RSI below 45, loss of SMA-200, negative revisions, or rising volatility and drawdown risk.
IRTC Decision Framework
Public evidence layers, setup checks, and risk context for iRhythm Technologies, Inc..
iRhythm Technologies, Inc. (IRTC) Stock Analysis
iRhythm Technologies, Inc. has an AIQ Score of 44/100 in a Bearish regime. Quality is strongest at 58/100. Beta is 0.5, below market sensitivity. Review the supporting stock factors together before drawing a conclusion from any single score.
| Evidence Layer | Public Evidence |
|---|---|
| Regime Context | IRTC is in a Bearish AIQ regime with score 44/100. |
| Signal Conflict | The primary conflict is that quality leads at 58/100 while momentum lags at 34/100. |
| Factor Evidence | Momentum 34/100 · Value 43/100 · Quality 58/100 · Risk 44/100 |
| Persistence | Current snapshot evidence is shown; historical persistence remains in AIQ Pro. |
Current Setup Checklist
Quality is the strongest factor at 58/100.
Momentum is 34/100 and RSI (14) is 35.3.
IRTC is in a Bearish regime at 44/100.
Risk factor is 44/100 with beta 0.5 and annual volatility 54.02%.
Current conflict: quality leads at 58/100 while momentum lags at 34/100.
IRTC Research Cluster
Ticker-specific paths for valuation, technical analysis, catalysts, dividends, financials, risk, and news.
IRTC Fundamentals
IRTC valuation, profitability, growth, margins, balance-sheet strength, and free cash flow.
IRTC Technical Analysis
IRTC technical setup based on RSI, MACD, moving averages, AIQ Momentum, volume, trend, volatility, and pivots.
IRTC Stock Catalysts
Track IRTC earnings, analyst ratings, price targets, estimate revisions, stock news, and upcoming events.
IRTC Dividend Analysis
IRTC dividend yield, annual dividend, payout ratio, payment history, and income reliability context.
IRTC Financial Data
IRTC revenue, earnings, income statement, balance sheet, cash flow, valuation ratios, and stock metrics.
IRTC Risk Analysis
IRTC volatility, beta, drawdown, Sharpe ratio, VaR, and downside resilience.
IRTC Stock News
IRTC stock news, market tone, recent headlines, and catalyst context.
IRTC vs Medical - Devices Peers
Current peer cohort: IRTC · ITGR · LIVN · NEOG · PACB. Compare AIQ, factor scores, Sharpe ratio and 1-year volatility in one indexable view.
| Peer | AIQ | Value | Momentum | Risk | Sharpe | 1Y Volatility | Compare |
|---|---|---|---|---|---|---|---|
| IRTC Current stock | 44/100 | 43/100 | 34/100 | 44/100 | -0.91 | 54.02% | Current |
| ITGR Integer Holdings Corporation | — | — | 85/100 | 80/100 | 2.02 | 31.24% | IRTC vs ITGR |
| LIVN LivaNova PLC | 71/100 | 60/100 | 83/100 | 71/100 | 1.38 | 39.16% | IRTC vs LIVN |
| NEOG Neogen Corporation | 63/100 | 49/100 | 74/100 | 57/100 | 1.19 | 57.93% | IRTC vs NEOG |
| PACB Pacific Biosciences of California, Inc. | 48/100 | 23/100 | 84/100 | 24/100 | 0.61 | 93.55% | IRTC vs PACB |
Peer cohort is resolved dynamically from the AlgovestIQ universe taxonomy and Compare relationship graph. Data as of Nov 18, 2026.
About the AIQ Score
Methodology for the current stock evidence.
The AlgovestIQ AIQ Score combines multiple dimensions of stock evidence, including momentum, valuation exposure, quality, risk resilience, sentiment context, and timing signals. It is a descriptive research score, not a guarantee of future performance or a personalized recommendation.
View AIQ methodologyFactor Diagnostics
A compact bridge from the AIQ score to the evidence tabs.
Open the return calculator with stock context while purchase price, shares, dates and fees remain user inputs.
Also for IRTC: historical return with reinvested dividends, dollar-cost averaging (DCA) backtest and stock average calculator for several buys.
AIQ Component Profile
Compare the five component scores on one consistent 0–100 scale.
Review earnings timing, revisions, news pressure, and prior event reactions in one place.
Open catalysts8 recent quarterly periods are available for review.
Checked Nov 19, 2026
Explore factor drivers, conflicts, persistence, and scenario sensitivity in the advanced workspace.
Fundamentals Verdict
Current snapshot fields are separate from reported-quarter statement tables.
Latest period Sep 30, 2026.
Market Confirmation
Technicals are summarized first, with the indicator library behind it.
Risk Alignment
Higher resilience is stronger; exposure metrics stay separate.
Continue Researching IRTC
Open the detailed evidence pages and workflows behind the stock overview read.
Premium Feature
Full AIQ Analysis
AIQ Intelligence
AIQ Pro for IRTC
Scenario Analysis
AIQ Scenario Builder
Portfolio Implication
Related Links
IRTC Stock FAQ
What is IRTC stock price today?
iRhythm Technologies, Inc.'s current stock price is $94.87. Use the live quote with AIQ Score, news, and risk context rather than treating price alone as a decision signal.
Is IRTC bullish or bearish right now?
IRTC's bullish or bearish read depends on the current AIQ Score, factor alignment, technical analysis consensus, valuation, risk, and catalyst evidence. A mixed setup should be treated differently from a broad confirmation across those signals.
What is IRTC's market cap?
IRTC's market cap is $3.04B based on the latest completed market-close snapshot from Nov 18, 2026. Use it with P/E ratio, revenue, and growth metrics to frame company size, valuation, and peer comparisons.
What is IRTC's current P/E ratio?
IRTC's current P/E ratio is -76.64 based on the latest completed market-close snapshot from Nov 18, 2026. Read it with revenue growth, margins, EPS, cash flow, and peer valuation rather than using P/E alone.
What is IRTC's RSI?
IRTC's 14-day RSI is 35.33 based on the latest completed market-close snapshot from Nov 18, 2026. RSI should be interpreted with MACD, moving averages, volume, volatility, and price trend.
Is IRTC above its 50-day and 200-day moving averages?
IRTC is -17.76% from its 50-day SMA and -23.15% from its 200-day SMA based on the latest completed market-close snapshot from Nov 18, 2026. Moving-average position should be read with momentum and broader AIQ evidence.
When is IRTC's next earnings date?
IRTC's next earnings date is currently listed as Feb 18, 2027. Earnings can reset revenue, EPS, price target, analyst rating, and catalyst expectations.
Does IRTC pay a dividend?
IRTC's dividend yield is 0.00% based on the latest completed market-close snapshot from Nov 18, 2026. Dividend yield should be read with payout ratio, free cash flow, growth, and balance-sheet strength.